AB Sciex and Indigo BioSystems have announced an agreement to jointly market mass spectrometry solutions that streamline data acquisition and automate data review to ensure high quality results in clinical research, forensic toxicology and pre-clinical and clinical trials of new drugs.
AB Sciex and Indigo BioSystems have announced an agreement to jointly market mass spectrometry solutions that streamline data acquisition and automate data review to ensure high quality results in clinical research, forensic toxicology and pre-clinical and clinical trials of new drugs.
This joint venture is expected to accelerate the use of new-generation mass spectrometry technologies for those who are accustomed to using easy-to-use lab analysers.
Joe Anacleto, vice president of Applied Markets and Clinical Research, AB Sciex, said, “Automation is an important step to accelerate the adoption of new-generation mass spectrometry for clinical research, forensics and clinical trials. Our relationship with Indigo BioSystems allows us to bring LC–MS–MS solutions to researchers who may not ordinarily consider mass spectrometry but can now have the assurance of a simplified workflow while getting all the attractive benefits of LC–MS–MS technology.”
Raul Zavaleta, Indigo CEO, commented, “By embedding the knowledge of assay experts into the analysis software, we provide the foundation for smarter research laboratories. We are pleased to be partnering with the industry leader in LC–MS–MS to achieve this goal.”
For more information please visit ref="http://www.absciex.com">www.absciex.com
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.